Bionime Corporation, Rightest GM260 Blood Glucose Monitoring System (17308)

Specialty: General Chemistry


Welcome to the PulseAid listing for the Bionime Corporation, Rightest GM260 Blood Glucose Monitoring System medical device. This device is used in the General Chemistry healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Chemistry healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Glucose monitoring devices (FDA cleared/home use) (K092052 | K092052) CLIA WAIVED
Effective Date: 2010-09-01

Other General Chemistry Devices:

Medical DeviceComplexity
Apex Biotechnology Corporation MEG-2 Multi Blood Glucose Monitoring SystemView Complexity
BECKMAN SYNCHRON CX SYSTEMSView Complexity
CARESIDE CARESIDE ANALYZERView Complexity
NOVA STAT PROFILE PHOXView Complexity
Roche Diagnostics cobas c 702 haptoglobinView Complexity
Siemens Dimension Vista 1000TView Complexity
AVL OMNI Combi AnalyzerView Complexity
Beckman Access Immunoassay SystemView Complexity
Baxter Paramax 720 ZXView Complexity
Roche Diagnostics Cobas Integra 400 PlusView Complexity